DHTRF (DRI Healthcare Trust) Retained Earnings : $-28.9 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DRI Healthcare Trust Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. DRI Healthcare Trust's retained earnings for the quarter that ended in Sep. 2024 was $-28.9 Mil.

DRI Healthcare Trust's quarterly retained earnings declined from Mar. 2024 ($-11.9 Mil) to Jun. 2024 ($-20.8 Mil) and declined from Jun. 2024 ($-20.8 Mil) to Sep. 2024 ($-28.9 Mil).

DRI Healthcare Trust's annual retained earnings declined from Dec. 2021 ($5.0 Mil) to Dec. 2022 ($-1.2 Mil) and declined from Dec. 2022 ($-1.2 Mil) to Dec. 2023 ($-2.2 Mil).

DRI Healthcare Trust Retained Earnings Historical Data

The historical data trend for DRI Healthcare Trust's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust Retained Earnings Chart

DRI Healthcare Trust Annual Data

Trend

Dec21

Dec22

Dec23

Retained Earnings

4.95

-1.24

-2.16

DRI Healthcare Trust Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial										39.70	-2.16	-11.95	-20.79	-28.89

DRI Healthcare Trust Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

DRI Healthcare Trust (OTCPK:DHTRF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

DRI Healthcare Trust Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (OTCPK:DHTRF) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

3IJ0:Germany DHT.UN:Canada DHT.U:Canada

Address

100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1

Website

https://www.dricapital.com

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.